Co-op Scientific Data Support Analyst, mRNA Center of Excellence

Initial Therapeutics, Inc.; Waltham (MA); On-site; USD 37,000 - 65,000; Part time

Job summary

Sanofi in Waltham, MA, is offering a 2027 Spring Co-op as a Scientific Data Support Analyst in the mRNA Center of Excellence within Vaccines. You will help align data sets and build digital tools to support scientists, while learning from mentors in a collaborative team environment.

The role emphasizes data management, dashboard development, and FAIR data principles, with opportunities to grow in a cutting-edge biopharma setting and participate in a 400m annual investment in next-generation

Qualifications

• Pursuing a degree in Life Sciences, Engineering, or related field with expected graduation Spring 2029.
• Authorized to work in the U.S. without sponsorship.
• Enrolled in a college/university for the duration of the co-op.
• Willing to relocate to Waltham and commit to 40 hrs/week.

Responsibilities

• Review and analyze current data practices in lab departments.
• Develop data pipelines to integrate diverse data sources.
• Create dashboards and visualizations to aid decision-making.
• Support R&D initiatives with data analytics.
• Ensure OT-IT data integration for lab equipment.
• Collaborate with senior leaders to improve data quality per FAIR principles.

Skills

Python

R

SQL

Power BI

Tableau

Data analysis

Communication skills

English

Education

Bachelor's or Master's degree in Life Sciences or related field

Graduating Spring 2029

Tools

Power BI

Tableau

Python

R

SQL

Job description

Sanofi in Waltham, MA, is offering a 2027 Spring Co-op as a Scientific Data Support Analyst in the mRNA Center of Excellence within Vaccines. You will help align data sets and build digital tools to support scientists, while learning from mentors in a collaborative team environment.

The role emphasizes data management, dashboard development, and FAIR data principles, with opportunities to grow in a cutting-edge biopharma setting and participate in a 400m annual investment in next-generation